From: Evaluation of cardioprotection and bio-efficacy enhancement of stevioside and diltiazem in rats
Treatment | Heart rate | RR (ms) | QRS (ms) | QT (ms) | PR (ms) |
---|---|---|---|---|---|
Normal control | 191.64 ± 7.39 | 187.96 ± 4.43 | 137.26 ± 3.31 | 196.51 ± 3.34 | 62.85 ± 4.59 |
ISO control | 298.52 ± 10.83*** | 288.74 ± 4.26*** | 183.52 ± 2.98*** | 263.39 ± 3.65*** | 113.70 ± 3.89*** |
DTZ | 238.48 ± 7.15***### | 254.8 ± 2.64***### | 162.20 ± 1.56***## | 220.86 ± 2.38***### | 85.23 ± 2.11**### |
STV 100 | 268.59 ± 14.73***### | 261.83 ± 1.48***### | 162.91 ± 2.97***## | 234.06 ± 1.79***### | 94.95 ± 1.11***## |
STV 200 | 242.10 ± 9.47***### | 253.45 ± 3.08***### | 164.46 ± 2.92***## | 218.12 ± 2.00**### | 84.73 ± 1.15**### |
STV 100+ DTZ | 227.29 ± 4.38***### | 249.40 ± 0.83***### | 157.60 ± 1.35***### | 220.24 ± 4.06**### | 85.58 ± 2.78**### |
STV 200 + DTZ | 211.53 ± 5.96###οο | 237.56 ± 1.78*###ο | 146.47 ± 3.38###ο | 199.73 ± 3.34###οο | 68.70 ± 3.72###ο |